Worked Example: Scaling Clearance From Adults to Neonates

From Adult Clearance to a Neonatal Prediction

A body-weight adjustment alone predicts how clearance changes with size, but it does not account for the fact that drug-eliminating pathways may be less developed in a neonate than in an adult. A useful worked calculation therefore has two distinct parts: first scale adult clearance to neonatal body weight, then adjust each pathway contribution for its degree of maturation. Keeping these steps separate makes the assumptions visible and makes the size-only prediction a clear comparator.

The calculation below is an approximation for a specified neonatal age and clinical context. The maturation factors must describe the relevant pathway at that age; they are not universal constants for all neonates or drugs. All numerical data in the examples are hypothetical.

The \(f_j\) values are adult pathway shares, not shares of enzyme abundance or fractions of the dose. The \(M_{j,N}\) values are dimensionless: \(M_{j,N}=1\) means no additional maturation reduction relative to the size-scaled adult pathway contribution, while a value below 1 reduces that contribution. Values above 1 are possible if a pathway’s per-size capacity is greater than the adult reference, although that requires an appropriate biological justification. The weighted sum is a single overall maturation multiplier only because the pathways are being treated as additive components of clearance.

Why the Weighted Maturation Factor Appears

The calculation follows from writing adult total clearance as the sum of adult pathway-specific clearances. If pathway \(j\) contributes fraction \(f_j\), its adult contribution is \(f_jCL_{adult}\). Under the stated model, that contribution is first scaled by the common body-weight factor and then multiplied by the pathway’s maturation factor.

In equations, this gives

The factorization is valid here because the model assumes one shared size exponent for all pathways and additive contributions on the same clearance basis. It also shows why a single unweighted average of the maturation factors is generally wrong: pathways contribute in proportion to their adult shares \(f_j\), not equally by default.

Comparing Size-Only and Maturation-Adjusted Predictions

Size-only scaling answers a limited question: what clearance would be predicted if adult pathway capacity scaled with body weight according to the selected exponent, with no additional developmental adjustment? The maturation-adjusted calculation answers a different question: how does that prediction change when specified pathways have neonatal capacities below or above their adult levels after size scaling?

These are not competing estimates of the same assumptions. The first is a useful benchmark; the second adds pathway-development information. A difference between them is expected when the weighted maturation factor differs from 1. When every \(M_{j,N}=1\), the adjusted expression reduces exactly to the size-only prediction.

Assumptions, Diagnostics, and Limits

Before interpreting a prediction, check that the calculation’s assumptions fit the available PBPK representation. Adult clearance and neonatal clearance must use the same measurement basis, such as blood clearance compared with blood clearance, and the weights must be in the same units. The adult pathway fractions should refer to the same total clearance being scaled, be nonnegative, and sum to 1 apart from rounding. Maturation factors should correspond to the specified neonatal developmental state and should match the pathway definition used for those fractions.

The shared 0.75 exponent is a modeling choice, not a mathematical consequence of the maturation factors. It assumes the same allometric size relationship for all included pathways. The calculation also treats the pathway contributions as additive and applies maturation as a multiplier to each contribution. If a pathway is not represented in the adult clearance decomposition, the fractions do not sum to 1; silently renormalizing the listed fractions would change the model rather than fix missing information.

For a PBPK model in which a change in intrinsic clearance affects hepatic extraction, simply multiplying observed systemic clearance by a maturation factor may not reproduce the model’s prediction. For example, organ blood flow, binding, and extraction can influence the relationship between intrinsic capacity and systemic clearance. In that situation, apply the developmental change to the relevant mechanistic parameter and recompute the organ model, rather than assuming the aggregate clearance multiplier is exact. Likewise, renal filtration and secretion should not be collapsed into a metabolic maturation factor unless the model explicitly defines and supports that representation.

Useful checks include verifying that the size factor is dimensionless, that the final clearance retains units of L/h, and that the weighted maturation factor equals 1 when all pathway factors equal 1. If all \(M_{j,N}\) values lie between 0 and 1, the adjusted prediction cannot exceed the size-only prediction under this formula. A result that violates that check usually signals an arithmetic or coding error. A prediction can still be biologically implausible even when the arithmetic is correct: uncertain adult pathway shares, inappropriate maturation inputs, an unsuitable exponent, or an omitted pathway can all produce misleading precision.

Common Pitfall

This simple method is most useful as a transparent calculation when a pathway decomposition and suitable maturation factors are available. It is a prediction from stated inputs, not a substitute for checking whether those inputs and the clearance representation match the drug and population being modeled.